Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study
European Journal of Cancer · 2024-09 · 209 · 114227
DOI: 10.1016/j.ejca.2024.114227 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Cancer, 2024-09. Verfasst von Mohammad Reza Darbandi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Computing, University of Georgia, Athens, GA, USA. Electronic address: darbandi@uga.edu. Hauptthemen laut MEDLINE: Artificial Intelligence, Breast Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 121 Literaturangaben.
Abstract (Originalsprache)
This article delves into the potential of artificial intelligence (AI) to enhance early breast cancer (BC) detection for improved treatment outcomes and patient care. Utilizing a multimethod approach comprising literature review and experiments, the study systematically reviewed 310 articles utilizing 30 diverse datasets. Among the techniques assessed, recurrent neural network (RNN) emerged as the most accurate, achieving 98.58 % accuracy, followed by genetic principles (GP), transfer learning (TL), and artificial neural networks (ANNs), with accuracies exceeding 96 %. While conventional machine learning (ML) methods demonstrated accuracies above 90 %, DL techniques outperformed them. Evaluation of BC diagnostic models using the Wisconsin breast cancer dataset (WBCD) highlighted logistic regression (LR) and support vector machine (SVM) as the most accurate predictors, with minimal errors for clinical data. Conversely, decision trees (DT) exhibited higher error rates due to overfitting, emphasizing the importance of algorithm selection for complex datasets. Analysis of ultrasound images underscored the significance of preprocessing, while histopathological image analysis using convolutional neural networks (CNNs) demonstrated robust classification capabilities. These findings underscore the transformative potential of ML and DL in BC diagnosis, offering automated, accurate, and accessible diagnostic tools. Collaboration among stakeholders is crucial for further advancements in BC detection methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Computing, University of Georgia, Athens, GA, USA. Electronic address: darbandi@uga.edu.
- Fetal Health Research Center, Hope Generation Foundation, Tehran, Iran. Electronic address: mahsaadarbandi@gmail.com.
- Gene Therapy and Regenerative Medicine Research Center, Hope Generation Foundation, Tehran, Iran. Electronic address: saraadarbandi@gmail.com.
- Department of Oncological Sciences, Tisch Cancer Institute, New York, USA. Electronic address: igor.bado@mssm.edu.
- Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: omhadizadeh@gmail.com.
- Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; Personalized Medicine and Genometabolics Research Center, Hope Generation Foundation, Tehran, Iran. Electronic address: h…
Zitieren
APA
Darbandi, M. R., Darbandi, M., Darbandi, S., Bado, I., Hadizadeh, M., & Khorram Khorshid, H. R. (2024). Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study. European Journal of Cancer, 209, 114227. https://doi.org/10.1016/j.ejca.2024.114227
Vancouver
Darbandi MR, Darbandi M, Darbandi S, Bado I, Hadizadeh M, Khorram Khorshid HR. Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study. European Journal of Cancer. 2024;209:114227. doi:10.1016/j.ejca.2024.114227
BibTeX
@article{Darbandi2024,
author = {Darbandi, Mohammad Reza and Darbandi, Mahsa and Darbandi, Sara and Bado, Igor and Hadizadeh, Mohammad and Khorram Khorshid, Hamid Reza},
title = {Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study},
journal = {European Journal of Cancer},
year = {2024},
volume = {209},
pages = {114227},
doi = {10.1016/j.ejca.2024.114227}
}
EUVIMED